Michael S. Lawrence

Affiliations: 
Massachusetts General Hospital Cancer Center 
Google:
"Michael Lawrence"

Parents

Sign in to add mentor
David P. Bartel grad student 1998-2005 MIT (Chemistry Tree)
David R. Liu post-doc 2005-2008 Harvard (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mishra A, Huang SB, Dubash T, et al. (2024) Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Biorxiv : the Preprint Server For Biology
Kawale AS, Ran X, Patel PS, et al. (2024) APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability. Science Advances. 10: eadk2771
Lee H, Blumberg B, Lawrence MS, et al. (2023) Revisiting the use of structural similarity index in Hi-C. Nature Genetics. 55: 2049-2052
Takahashi M, Chong HB, Zhang S, et al. (2023) DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Biorxiv : the Preprint Server For Biology
Wang M, Ran X, Leung W, et al. (2023) ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy. Genes & Development
Yang H, Lachtara EM, Ran X, et al. (2023) The RNA m5C modification in R-loops as an off switch of Alt-NHEJ. Nature Communications. 14: 6114
Sanidas I, Lawrence MS, Dyson NJ. (2023) Patterns in the tapestry of chromatin-bound RB. Trends in Cell Biology
Butt Y, Sakhtemani R, Mohamad-Ramshan R, et al. (2023) Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations. Biorxiv : the Preprint Server For Biology
Choudhuri SP, Girard L, Lim JYS, et al. (2023) Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of paralogs. Biorxiv : the Preprint Server For Biology
Isozaki H, Sakhtemani R, Abbasi A, et al. (2023) Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature
See more...